1. Home
  2. HBNC vs AUTL Comparison

HBNC vs AUTL Comparison

Compare HBNC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBNC
  • AUTL
  • Stock Information
  • Founded
  • HBNC 1873
  • AUTL 2014
  • Country
  • HBNC United States
  • AUTL United Kingdom
  • Employees
  • HBNC N/A
  • AUTL N/A
  • Industry
  • HBNC Major Banks
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HBNC Finance
  • AUTL Health Care
  • Exchange
  • HBNC Nasdaq
  • AUTL Nasdaq
  • Market Cap
  • HBNC 678.2M
  • AUTL 625.4M
  • IPO Year
  • HBNC N/A
  • AUTL 2018
  • Fundamental
  • Price
  • HBNC $16.23
  • AUTL $2.29
  • Analyst Decision
  • HBNC Hold
  • AUTL Strong Buy
  • Analyst Count
  • HBNC 2
  • AUTL 5
  • Target Price
  • HBNC $17.00
  • AUTL $9.32
  • AVG Volume (30 Days)
  • HBNC 162.8K
  • AUTL 2.0M
  • Earning Date
  • HBNC 07-23-2025
  • AUTL 08-07-2025
  • Dividend Yield
  • HBNC 3.90%
  • AUTL N/A
  • EPS Growth
  • HBNC 88.54
  • AUTL N/A
  • EPS
  • HBNC 1.02
  • AUTL N/A
  • Revenue
  • HBNC $201,164,000.00
  • AUTL $9,011,000.00
  • Revenue This Year
  • HBNC $46.44
  • AUTL $461.76
  • Revenue Next Year
  • HBNC $4.83
  • AUTL $112.66
  • P/E Ratio
  • HBNC $16.08
  • AUTL N/A
  • Revenue Growth
  • HBNC 11.46
  • AUTL N/A
  • 52 Week Low
  • HBNC $11.97
  • AUTL $1.11
  • 52 Week High
  • HBNC $19.18
  • AUTL $5.00
  • Technical
  • Relative Strength Index (RSI)
  • HBNC 64.17
  • AUTL 60.00
  • Support Level
  • HBNC $15.71
  • AUTL $2.20
  • Resistance Level
  • HBNC $16.49
  • AUTL $2.44
  • Average True Range (ATR)
  • HBNC 0.41
  • AUTL 0.11
  • MACD
  • HBNC 0.14
  • AUTL -0.02
  • Stochastic Oscillator
  • HBNC 83.95
  • AUTL 60.22

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: